Researchers at Griffith University report encouraging progress toward treating sepsis after a Phase II clinical trial in China produced positive results. The study suggests a new drug candidate may reduce the severity of sepsis, a condition that…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply